Quantitative and qualitative analysis of the quality of life of type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections
Batch potency varies: Testing shows up to 20% variability between batches
The study discovered that over 40,000 of the 70,000+ participants taking a GLP-1 drug, like Ozempic, quit within one year, and 42% of the participants stopped within nine months
This might lead to fluctuations in blood sugar, causing levels to drop too low or rise unexpectedly
18, 2025 (GLOBE NEWSWIRE) -- As demand for medically supervised weight management continues to rise across the United States, telehealth platforms focused on GLP-1based treatment access are gaining heightened visibility in 2025-2026
Hormetic effect of rotenone in primary human fibroblasts